Gold tier: mechanically validated evidence, with its primary source.
8,823 evidence items · page 53 / 353
3.01 odds_ratioMultiple stepwise logistic regression showed that statin use is a common negative predictor or probable protective factor for PAD with odds ratio 3.01, 95% confidence interval 1.99–9.19, and p = 0.023.
NigeriaAOMIpublished 2023Foot (Edinburgh, Scotland)PubMeddocument of 23 observations
72 %Treatment of malaria was with boiled herbs ('agbo') in 72% of cases reported by traditional healers.
Nigeriapaludismepublished 2007International quarterly of community health educationeurope_pmcdocument of 9 observationsDOI 10.2190/iq.28.4.e
73 %Seventy-three percent of the respondents noted that hydroxyurea reduced transfusion rates in patients with sickle cell disease.
Nigeriadrépanocytosepublished 2019HemoglobinPubMeddocument of 7 observations
425 participantsIn a cross-sectional survey, 425 adult people living with HIV (PLHIVs) attending a tertiary hospital in Nigeria self-reported their 28-day adherence to highly active antiretroviral therapy (HAART).
NigeriaVIH/sidapublished 2020Ghana medical journalPubMeddocument of 7 observations
36.1 %The prevalence of hypertension among older adults in Olorunda Local Government, Osun State, Nigeria was 36.1%.
Nigeriahypertension artériellepublished 2020Ghana medical journalPubMeddocument of 5 observations
83.5 %At the pre-intervention stage, 83.5% of female secondary school students had low HPV knowledge.
Nigeriainfection à HPVPubMeddocument of 7 observations
862 patientsHealth records of 862 patients with breast cancer were analysed across six tertiary care institutions in Ghana, Kenya, and Nigeria.
Ghana · Kenya · Nigeriacancer du seinobserved 2014 to 2017published 2021BMJ openPubMeddocument of 13 observations
49.5 %Almost half (49.5%) of the study participants gained weight after ART initiation.
NigeriaVIH/sidapublished 2025Frontiers in public healthPubMeddocument of 7 observations
90 %For triple-negative breast cancer, highest versus lowest CLEEE tertile was associated with 90% higher breast cancer odds.
Nigeriacancer du sein triple-négatifpublished 2026Breast cancer research and treatmentPubMeddocument of 10 observations
14 %HIV prevalence among MSM increased from 14% in 2007 to 17% in 2010 to 23% in 2014.
NigeriaVIH/sidaobserved 2007published 2019BMC public healthPubMeddocument of 12 observations
0.965 rA positive significant correlation was observed between total cholesterol and LDL (r = 0.965, p < 0.0001) in the breast cancer patients.
Nigeriacancer du seinpublished 2025Breast cancer (Tokyo, Japan)PubMeddocument of 8 observations
69.8 %The prevalence of albuminuria among elderly patients with Type 2 Diabetes Mellitus (T2DM) was 69.8%.
Nigeriadiabète de type 2published 2022The Pan African medical journalPubMeddocument of 20 observations
4.9 %The proportion of tuberculosis patients lost to follow up was 4.9%.
Nigeriatuberculoseobserved 2012-2016published 2022African health sciencesPubMeddocument of 17 observations
605 clientsA total of 605 newly-diagnosed clients were enrolled into the study.
NigeriaVIH/sidapublished 2025BMC public healthPubMeddocument of 8 observations
31.4 %Among persons with Type 2 Diabetes Mellitus, 31.4% had a coexisting depression and anxiety disorder.
Nigeriaanxiety disorder · dépression · diabète de type 2published 2024West African journal of medicinePubMeddocument of 7 observations
22.2 %OSS accounted for 22.2% of the 3737 patients with known viral load.
NigeriaVIH/sidaobserved May 2022 to May 2023published 2026BMC public healthPubMeddocument of 9 observations
3.27 cmLeft atrium dimension was significantly higher in HIV-positive subjects on HAART (3.27 cm).
NigeriaVIH/sidapublished 2021Cardiovascular journal of AfricaPubMeddocument of 9 observations
29.2 %Among 209 parents of children with SCD in Ibadan, Nigeria, 29.2% discovered their sickle cell phenotype only after having a child with SCD or during a health crisis.
Nigeriadrépanocytosepublished 2025BMC public healthPubMeddocument of 5 observations
88.8 %Among 21,621 seasonal malaria chemoprevention-targeted children in Nigeria, 88.8% received Day 1 sulfadoxine-pyrimethamine plus amodiaquine and both Day 2 and Day 3 amodiaquine.
Nigeriapaludismeobserved 2021, 2022published 2024Tropical medicine & international health : TM & IHPubMeddocument of 7 observations
63.4 %The LAM10_CAM genetic family accounted for 128 out of 202 (63.4%) Mycobacterium tuberculosis complex isolates in Nigeria.
Nigeriatuberculosepublished 2019Journal of epidemiology and global healthPubMeddocument of 7 observations
50 %Minor PI resistance-associated mutation L10V/I was identified in 50% of CRF02_AG HIV-1 isolates.
NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 11 observations
71.1 %La prévalence de la neuropathie périphérique diabétique était de 71,1 % au Nigeria.
Nigerianeuropathie périphériqueHAL · Unilimdocument of 747 observations
0.07 kappaMeasures of agreement between ECG and cTnT in detecting myocardial injury were poor during VOC (κ 0.07, p = 0.68).
Nigeriadrépanocytosepublished 2020Paediatrics and international child healtheurope_pmcdocument of 8 observations
16.7 %Histoplasmosis accounted for 16.7% (n = 19) of the 114 reported IFI cases in the Nigerian paediatric population.
Nigeriahistoplasmosisobserved 1964–2023published 2025Journal de mycologie medicalePubMeddocument of 17 observations
1,700,000 inhabitantsIn 2021, 1.7 million people living with HIV in Nigeria were on antiretroviral therapy (ART).
NigeriaVIH/sidaobserved 2021published 2024Journal of research in health sciencesPubMeddocument of 5 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.